yego.me
💡 Stop wasting time. Read Youtube instead of watch. Download Chrome Extension

The Challenges with Cancer Trials | Breakthrough


2m read
·Nov 11, 2024

ANDRE CHOULIKA: We didn't have any intention of injecting these type of vials to patient because we needed a lot of vials to be able to file our clinical trial application. And this was planned to be done with the University College London.

NARRATOR: Before any new medication or therapy is considered safe and effective, it must first be rigorously tested through clinical trials. These trials are fundamental in determining an experimental treatment's dosage and safety and to identify any possible side effects. At the University College London, Great Ormond Street Institute of Child Health, Professor Waseem Qasim was working with Cellectis as the principal investigator, taking the universal CAR T-cells from the lab to trials.

Normally, this process can take over a decade, with nearly endless layers of approval. So our questions were what do you do if your patient is already so unwell that you can't collect cells; or has had so much chemotherapy that there's no white blood cells left to collect, that you think are going to be useful; how do you do this process in a way that can be done quickly and delivered back to the patient in a timely manner?

And the answer to that is perhaps being able to use a product, a cell product, that's been made beforehand, that can be given back to multiple patients. Now in order to do that, we have to overcome the barrier of transplantation, which means if I put my cells into a nonmatched individual, the cells firstly will want to react against that individual because they will know the individuals is foreign. And secondly, the person receiving the cells will try and reject them because they know the cells are not their own.

NARRATOR: In affiliation with Professor Qasim, Doctor Paul Veys works on the front line with patients who desperately need new cancer treatment options. I'll have treated well over 3,000 patients and at least 600 of those will have gone wrong. So there's a lot of patients that we lose. It's unsuccessful. You've got to be able to come in the next day. Even from our failures, we've learned lots. And if we hadn't gone through those failures, we wouldn't be having some of the successes we have today.

Has the chest always been good? He's not had any big chest infections? NURSE: No. It's not good. Let's warm it up. Sit forward again. Yeah. Perfect. OK. Big breaths.

More Articles

View All
watch this if you always procrastinate
If this sounds like you, please watch this video. You are a highly intellectual individual who wants to improve their life in any sort of area. You started to look for options and ways to improve your life and deepen your knowledge about self-improvement,…
Fraction multiplcation on the number line
So we’re going to think about, in this video, is multiplying fractions. So let’s say that we wanted to take two-thirds, and we want to multiply it by four. What is this going to be equal to? Pause this video and try to think about it on your own. All rig…
Gel electrophoresis | Biomolecules | MCAT | Khan Academy
Let’s say that you have some vials here, and you know that in the solution you have fragments of DNA in each of these. What you’re curious about is, well, what about the DNA fragments in this first vial, in vial number one? How long are those fragments? H…
The Stock Market is 'Priced to Insanity'.
The Magnificent 7 is seeing nice gains following Q4 earnings, with the group now up about 9% for the year. My next guest says while the names are richly priced, only one is quote priced to the point of insanity. Let’s bring in the Dean of Valuation, Aswat…
Can Afterpay Touch Take Over the US? - The Young Investors Podcast | Episode 2
Hey guys, welcome back to the Young Investors Podcast. We’re doing Episode 2. We somehow managed to front up for another week of podcasting. I’m joined as always by Hey Machado. Hey guys, it’s good to be back, and yeah, we’ve finally got a name for the p…
Capturing a Carnivorous Bat on Camera | National Geographic
[Music] When National Geographic asked me to photograph this bat story, I was really excited because it was an opportunity to work with some really interesting scientists, like Rodrigo. I get to work with the species I’ve never seen before. Very little h…